drug
VONJO
updated 3mo agoby Sobi Inc
community read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
News(1)
- Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 pushSobi has bought into Innate Pharma’s vision for lacutamab, handing the French biotech $75 million upfront for the rights to market the anti-KIR3DL2 antibody for an aggressive skin cancer.fiercebiotech · 8d ago
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that